Αποτελέσματα Αναζήτησης
Compare risks and benefits of common medications used for Anorexia Nervosa. Find the most popular drugs, view ratings and user reviews.
- Eating Disorders
Drugs.com provides accurate and independent information on...
- Eating Disorders
3 Ιουλ 2023 · Megestrol (Megace ES), dronabinol (Marinol, Syndros), and oxandrolone are FDA-approved appetite stimulants that can promote weight gain and nutritional intake when needed. Mirtazapine (Remeron) is an antidepressant that’s sometimes taken off-label to boost appetite. Cyproheptadine is a prescription antihistamine that is sometimes taken in this way.
Zyprexa (or olanzapine) is typically used to treat acute and mixed episodes of Schizophrenia while Seroquel (or quetiapine) is typically used to treat bipolar disorder. These antipsychotic medications have been shown through research to induce weight gain and help lessen the frequency and intensity of intrusive anorexic thoughts.
Treatment for anorexia nervosa (often called anorexia) usually involves a combination of talking therapy and supervised weight gain. It's important to start treatment as early as possible to reduce the risk of serious complications, particularly if you've already lost a lot of weight.
1 Ιουν 2019 · CY appears to be a safe, generally well-tolerated medication that has utility in helping facilitate weight gain in patients drawn from a variety of underweight populations. Future prospective randomized controlled studies in low weight patients that include objective measures of appetite and intake …
9 Αυγ 2024 · Unfortunately, no medicines have been found to help treat anorexia nervosa. For people who have anorexia, being underweight may interfere with the effectiveness of medicines they take for other conditions, including depression and anxiety. For people with anorexia, food is truly the medicine.
23 Μαΐ 2017 · Consider bisphosphonates for women (18 years and over) with anorexia nervosa who have long-term low body weight and low bone mineral density. Discuss the benefits and risks (including risk of teratogenic effects) with women before starting treatment.
